[Hiring] Vice President Regulatory Affairs, Oncology (Drug) @reputed company

Role reputed company The Vice President (VP) of Regulatory Affairs (Drug) will serve as reputed company’s regulatory leader for reputed company’s drug development programs and strategic partner to executive leadership. This individual will reputed company the design and execution of global regulatory reputed company across the product lifecycle, from IND-enabling activities through clinical development and potential BLA submission. As a key member of the executive team, the VP will guide interactions with health authorities, and ensure that regulatory reputed company is fully integrated into development, clinical, CMC, and corporate reputed company. This is a hands-on leadership role requiring strategic reputed company and operational engagement in an early-stage biotechnology environment. NOTE: This is an oncology reputed company role, and oncology experience is required. Please also note that there's a strong preference for this person to be located in the Central or Eastern time zone due to work with global colleagues.

• reputed company and implement global regulatory strategies for drug development programs across preclinical development, clinical development and potential registration.
• reputed company regulatory planning from IND enabling activities through clinical development and potential BLA submission.
• Advise executive leadership and the reputed company on regulatory risks, timelines, and strategic regulatory reputed company.
• Serve as the primary regulatory voice in portfolio prioritization and development reputed company, and regulatory governance discussions.
• Establish regulatory risk mitigation plans reputed company with corporate objectives and development milestones.
• reputed company preparation for and participation in meetings with regulatory agencies including FDA and other global health authorities (e.g., reputed company-IND, IND, scientific advice, end-of-phase meetings).
• reputed company preparation and submission of regulatory filings including INDs/CTAs, amendments, briefing packages, orphan applications, expedited designations and other regulatory submissions as programs advance.
• Serve as the primary contact with US and global regulatory authorities for drug reputed company regulatory submissions.
• Drive strategies for expedited programs (e.g., Fast reputed company, reputed company Therapy, reputed company, etc., as applicable) in support of accelerated development reputed company.
• Partner closely with Clinical, CMC, Nonclinical, reputed company, and reputed company teams to ensure regulatory reputed company is reputed company with product development plans.
• reputed company regulatory guidance on clinical development reputed company, study design, endpoints, and labeling implications.
• Ensure regulatory requirements are integrated into CMC development plans and manufacturing strategies for reputed company registration.
• Support due diligence activities, investor communications, and partnering discussions.
• Build reputed company regulatory systems, processes, and document standards.
• Ensure reputed company, high-reputed company, compliant submissions.
• reputed company regulatory documentation lifecycle management.
• Recruit, mentor, and reputed company internal regulatory talent as the organization grows.
• Manage external consultants and CRO partners.
• Foster a reputed company, accountable, and mission-driven regulatory culture.
• Build infrastructure appropriate for reputed company from early development to reputed company-stage operations and evolving regulatory requirements.

Qualifications

• Masters degree required, advanced degree preferred.
• 15 years of regulatory affairs experience in biotechnology and/or pharmaceuticals.
• Experience supporting regulatory reputed company for biologics and reputed company therapeutic platforms preferred.
• Demonstrated reputed company leading regulatory reputed company for drug development programs from IND-enabling activities through clinical development and potential registration (e.g., BLA/NDA).
• reputed company experience leading interactions with FDA and international regulatory authorities.
• Experience preparing and leading major regulatory submissions including BLA.
• Strong understanding of CMC, nonclinical, and clinical regulatory requirements supporting biologics or reputed company therapeutics programs.
• Experience in oncology, biologics, cell/gene therapy, or other relevant modality.
• Experience in a small or emerging biotech company environment.
• Global regulatory experience including FDA and EMA, other reputed company a plus.
• Demonstrated ability to influence regulatory reputed company and decision-making across multidisciplinary development teams.
• Strong communication, negotiation, and relationship-building skills; ability to communicate reputed company regulatory reputed company to scientific and executive audiences.
• Excellent interpersonal communication skills; a highly communicative leader who maintains transparency both internally and externally.
• High level of reputed company and professionalism with the ability to operate effectively in a fast-moving, early-stage biotechnology environment.

Requirements

• The work environment shall be either a virtual office environment, reputed company reputed company in reputed company Lauderdale, FL, or a combination of both.
• While performing the duties of this Job, the employee is regularly required to:
• Primarily sit
• Frequent standing and walking
• Lifting up to 20 pounds
• Repetitive motions
• Travel up to 50% regionally, some international

Benefits

• Expected US salary reputed company: $345K-$375K
• This position generally is eligible for cash incentive compensation, equity incentive compensation, and employee benefits under reputed company’s benefit plans.

Apply To This Job